GWQ: Full-Montage Standard Electroencephalograph
What it covers
Acquire, display, store, and archive electroencephalographic signals from the brain using a full montage array (i.e., 16 or more electrodes) and user-specified locations
FDA’s definition of product code GWQ, from the Product Classification database.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K261604 | Enobio Dx (Enobio Dx 8);Enobio Dx (Enobio Dx 20);Enobio Dx (Enobio Dx 32) | Neuroelectrics Barcelona S.L.U. | Jun 13, 2026 | Special |
| K260455 | New Wave System | Zeto, Inc. | Mar 13, 2026 | Special |
| K233403 | Flexset System | Zeto, Inc. | Apr 30, 2024 | Traditional |
| K231366 | Neuronaute Plus | Bioserenity Sas | Nov 9, 2023 | Traditional |
| K221959 | Q21 | Neurofield, Inc. | Aug 31, 2023 | Traditional |
| K231457 | SPARK Scan | Spark Neuro, Inc. | Aug 18, 2023 | Traditional |
| K221963 | Cumulus Functional Neurophysiology Platform | Cumulus Neuroscience Limited | Apr 27, 2023 | Traditional |
| K230073 | Okti | Compumedics Limited | Feb 9, 2023 | Traditional |
| K223644 | Neuronaute with IceCap 2 & IceCap 2 Small | Bioserenity | Jan 12, 2023 | Special |
| K220056 | iSyncWave | iMediSync, Inc. | Aug 10, 2022 | Traditional |
Clearances by year
49 GWQ 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 2 | 30 |
| 2024 | 1 | 209 |
| 2023 | 6 | 137 |
| 2022 | 3 | 216 |
| 2020 | 6 | 216 |
| 2018 | 8 | 150 |
| 2017 | 5 | 181 |
| 2016 | 3 | 50 |
| 2015 | 3 | 276 |
| 2014 | 2 | 189 |
| 2013 | 2 | 240 |
| 2012 | 4 | 208 |
| 2011 | 4 | 220 |
Who submits
36 applicants cleared a GWQ device since 2011. 55% of the clearances went to applicants in United States, then Canada (14%), France (8%) and Australia (4%). By type: Traditional 84%, Special 14% and Abbreviated 2%. 1 went through a third-party review organization.
| Applicant | Clearances since 2011 |
|---|---|
| Cadwell Industries, Inc. | 4 |
| Natus Medical Incorporated Dba Excel-Tech Ltd. (Xltek) | 3 |
| Neurovirtual USA, Inc. | 3 |
| Zeto, Inc. | 3 |
| Bioserenity | 2 |
| Bioserenity Sas | 2 |
| Neuroelectrics Barcelona S.L.U. | 2 |
| Nihon Kohden Corp. | 2 |
How FDA classifies it
Class II (performance standards).
From 21 CFR 882.1400.
Standards
21 CFR 882.1400 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent GWQ clearances declared.
Ask about GWQ
Questions about GWQ
What is FDA product code GWQ?
Product code GWQ, “Full-Montage Standard Electroencephalograph” in FDA's classification database, is a Class II device type under 21 CFR 882.1400 (electroencephalograph), reviewed by FDA's Neurology panel. FDA's 510(k) database lists 189 clearances under GWQ, 49 of them since 2011.
How many 510(k) clearances are there under GWQ?
FDA’s 510(k) database listed 189 clearances under GWQ as of Oct 29, 2026, 49 of them decided since 2011; the most recent decision was Jun 13, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a GWQ 510(k)?
For the 2 GWQ clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 30 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most GWQ clearances?
Since 2011: Cadwell Industries, Inc. (4), Natus Medical Incorporated Dba Excel-Tech Ltd. (Xltek) (3), Neurovirtual USA, Inc. (3), Zeto, Inc. (3) and Bioserenity (2). 36 applicants have cleared a GWQ device in that time.